NCT06280690View on ClinicalTrials.gov

SGM-101 Tumor Targeted Fluorescence Endoscopy in Rectal Polyps With Suspected T1 Adenocarcinoma or High Grade Dysplasia

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

July 30, 2025

Conditions
Colorectal CancerImageLow Grade Dysplasia of Colon
Interventions
DRUG

SGM-101

SGM-101 is cea-targeted fluorescent dye

Trial Locations (1)

2333ZA

RECRUITING

Leiden University Medical Center, Leiden

All Listed Sponsors
lead

Leiden University Medical Center

OTHER